Riskpilot← Back to searchSign inGet full accessLab-dig Oy
OYActiveY-tunnus 0100757-0Olarinluoma 14-BWholesale of pharmaceutical and medical goods · NACE 4646Est. 19731 employeeswww.labdig.fi
Revenue 2025
EUR 905K
+118% vs 2024
EBITDA margin
8.6%
+406% vs 2024
Equity ratio
67.9%
Financial strength
Net profit 2025
EUR 67K
+339% vs 2024
| Revenue | EUR 905K | +118% |
| EBITDA | EUR 78K | +406% |
| Net profit | EUR 67K | +339% |
| Total assets | EUR 152K | +3% |
| Equity | EUR 103K | +67% |
| Employees | 1 | — |
Legal name
Lab-dig Oy
Y-tunnus number
0100757-0
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. toukokuuta 1973
Share capital
EUR 8 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on laboratorio- ja sairaalatarvikkeiden tuonti, vienti, tukku- ja vähittäiskauppa sekä valmistus ja muu siihen liittyvä toiminta.
Address
Olarinluoma 14-B
Phone
+358098845022
Email
labdig@labdig.fi
Website
www.labdig.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 431 | 461 | 415 | 905 |
| Staff expenses | −95 | −85 | −92 | −102 |
| EBITDA | −19 | 8 | −25 | 78 |
| Depreciation & amort. | −3 | −3 | −0 | −0 |
| EBIT | −22 | 5 | −25 | 78 |
| Net financials | −0 | −0 | −2 | −3 |
| Profit before tax | −22 | 4 | −28 | 75 |
| Tax | −0 | −0 | −0 | 8 |
| Net profit | −22 | 4 | −28 | 67 |
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 190 | 224 | 147 | 152 |
| Equity | 101 | 98 | 62 | 103 |
| Long-term debt | 45 | 45 | 45 | 5 |
| Short-term debt | 44 | 81 | 40 | 43 |
| Total debt | 89 | 127 | 85 | 49 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20212025
Return on equity
64.6%
This company
18.4%
Market median
+251% vs market
20212025
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20212025
Asset turnover
5.95×
This company
1.12×
Market median
+431% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MT Deputy Member | Deputy Member | 2024 |
MJ Chief Executive Officer | Chief Executive Officer | 2019 |
EM Audit | Audit | 2024 |
MJ Deputy auditor | Deputy auditor | 2007 |
| Former (4) | ||
TJ Deputy Member | Deputy Member | 2017 – 2024 |
JP Chief Executive Officer | Chief Executive Officer | 2007 – 2019 |
JK | Audit | 2020 – 2023 |
TH Audit | Audit | 2007 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lab-dig Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Juhani Tuomi | Deputy Member | 0 companies |
| Jan-Erik Planting | Chief Executive Officer | 0 companies |
| Johanna Katariina Järvenpää | Audit | 0 companies |
| Mathias Tom Johan Kronholm | Deputy Member | 0 companies |
| Teija Helena Moisala | Audit | 0 companies |
| Mats Johan Daniel Peräsalo | Chief Executive Officer | 0 companies |
| Eva Maria Hiltunen | Audit | 0 companies |
| Matti Johannes Mäkinen | Deputy auditor | 0 companies |
| Denise Birgitta Öller | Board of Directors | 0 companies |